This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The internet is a vast resource of information on health and wellness. However, not all of this information is created equal. Some of it is accurate and reliable, while other information may be misleading or even harmful. This is especially true when it comes to pharmaceutical-sponsored health information.
The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceuticalcompany to disclose plans to change the way it will make payments.
Electronic product information (ePI) for selected human medicines has been published for the first time by the Heads of Medicines Agencies (HMA), the European Commission (EC) and the European Medicines Agency (EMA). According to the EMA, outcomes will inform how to integrate the ePIs into common practice and expand their use across the EU.
In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceuticalcompanies that could supply similar medicines.
Anyone picking up a prescription from their pharmacy is used to the reams of paper that typically accompany it: information on safety, storing, and how to use the drug. What if that information also included your medicine’s carbon footprint?
The BIOSECURE Act would prohibit many biotech and pharmaceuticalcompanies from conducting certain research and development activities, including the manufacturing of drugs through named Chinese companies. Protecting that information and being able to make our own medicines should be a national priority.
Three industry bodies have produced a joint position paper highlighting recommendations for adopting a harmonised implementation of electronic Product Information (ePI) leaflets. It will also enable more patient-centric and accessible content by providing the most up-to-date information.
WASHINGTON — The Biden administration is making its opening offers to pharmaceuticalcompanies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.
Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy. For pharmaceuticalcompanies, this can provide insights into public perception of drug launches, patient experiences, and industry discussions.
The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceuticalcompany to task for its marketing.
A loophole in prescription drug regulation exposes American consumers to false and misleading claims of drug ads via on-line businesses promoting potent drugs without accurate information about their risks and benefits. Many countries prohibit direct-to-consumer advertising of prescription drugs.
As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.
Better management of customer data could help pharmaceuticalcompanies’ digital transformation, according to Veeva’s Rebecca Silver. Personalised medicine is driving the need to get more information to more physicians. Personalised medicine is driving the need to get more information to more physicians.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceuticalcompanies and healthcare brands are allocating more resources to advertising in 2025. These drivers are reshaping how pharma companies and healthcare organizations allocate their marketing funds.
In order to succeed in this challenging environment, pharmaceuticalcompanies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs. It is also about changing the mindset of pharmaceuticalcompanies.
Table of Contents: Understanding Pharma Tariffs Impacts on Branded Drug Marketing Adjusting Digital Advertising Strategies Strategic Recommendations for Pharma Marketers Conclusion FAQs Understanding Pharma Tariffs Pharma tariffs are taxes imposed by governments on imported pharmaceutical products. How do pharma tariffs impact drug pricing?
But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceuticalcompanies, this means aligning sponsorships with causes that are related to health and wellness. In 2020, the company committed to investing $5 billion in research and development over the next five years.
… Some health care experts and doctors worry that an Eli Lilly plan to offer its Zepbound weight-loss drug directly may make it easier than ever for pharmaceuticalcompanies to target patients with their products, regardless of whether the medicine is the right treatment for a particular individual , The New York Times explains.
Sponsorships can be a powerful tool for pharmaceuticalcompanies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceuticalcompanies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.
government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceuticalcompany has been threatened with such a step. Continue to STAT+ to read the full story…
The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceuticalcompanies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail.
Content marketing can help businesses do this by providing valuable information about their products and services in a way that is compliant with all applicable regulations. For example, a pharmaceuticalcompany could create a blog post about a new drug that it is developing.
The Power of Patient-Centric Marketing Patients are no longer passive recipients; they’re informed stakeholders. Create short, informative TikTok videos about how your products improve lives. The key is to balance information with emotional storytelling. How can digital marketing benefit pharmaceuticalcompanies?
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceuticalcompanies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceuticalcompanies and patient and caregivers.”.
Collaborative partnerships between universities and pharmaceuticalcompanies are crucial for advancing biomedical research and development (R&D) and creating groundbreaking medicines. Explore the benefits and significance of these alliances in this informative piece.
Medical affairs is the bridge between pharmaceuticalcompanies and healthcare providers. It includes roles like Medical Science Liaisons (MSLs), who engage with providers, and Medical Information Specialists, who answer complex drug-related questions. And once he changed that, everything else followed.
Glasgow, UK (24th November, 2021) – Formedix , a leading provider of clinical trial software solutions, announces the launch of the Formedix ryze Community, to provide their customers with a location to collaborate, expand their knowledge and share information. For more information on the ryze Community, please see community.formedix.com.
Brand Authority: By appearing at the top of search engine results, pharmaceuticalcompanies increase brand credibility among HCPs. Use a mix of: Branded Keywords: Drug names, pharmaceuticalcompanies, or treatment-specific terms. Ensuring landing pages provide accurate and balanced medical information.
Companies are also helping patients understand where they can access labs, infusion centres or imaging centres, and are offering solutions to HCPs and their practices so they can more easily afford and keep stock of therapies. In fact, 61% said they are interacting with pharma sales reps more during COVID-19 than they did before.
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceuticalcompanies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape.
The German pharmaceuticalcompany has been working with New York-based One Drop on digital health products that span multiple therapeutic areas, including oncology and women’s health as well as CVD in the alliance , which was expanded last year in a $98 million deal.
The new General Practice Data for Planning and Research (GPDPR) service was unveiled earlier this month by NHS Digital, which described it as a way to “improve” the collection of patient information that would allow better planning of healthcare services and use of data in medical research.
Pharmaceuticalcompanies ask themselves this question before embracing the latest technologies because every innovation comes with both opportunities and risks. Rather than develop this capacity in-house, many companies enter into agreements with third-party AI developers or acquire companies with these capabilities.
Traditionally, pharmaceuticalcompanies have relied on demographics to target their marketing efforts. To create truly effective marketing campaigns, pharmaceuticalcompanies need to go beyond demographics and consider the psychographics of their target audience. Goals: What are consumers trying to achieve?
The pandemic has triggered a change in how pharmaceuticalcompanies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceuticalcompany engagement during the crisis. The answer was yes.
For example, they can be created from multiple sources of disease natural history information. Natural history information also describes the current standard of care or emergent care, which may alter disease morbidity and mortality. Two different methodologies are used in the application of HC information in clinical development.
Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue.
The incident raises questions about financial ties between Sarepta and the group, Parent Project Muscular Dystrophy, and whether the company uses its money to influence, or even muzzle, debate over its Duchenne medicines. The treatments, acquired in a $3.1 reduction in weight compared with a placebo after four weeks.
Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. For more information, visit veeva.com/eu.
The ways in which we communicate and consume information are constantly transforming. The word ‘dissemination’ has a passive connotation, implying a unidirectional flow of information,” said Robert Poole, director of strategic and scientific services at Complete HealthVizion.
In a document outlining the charges against Shafat Quadri, of North Potomac, Maryland the US Department of Justice (DoJ) referred only to “one of the largest pharmaceuticalcompanies in the world” based in New Jersey.
Introduction Pharmaceuticalcompanies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective?
Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. Her focus on gaining deep behavioural insights ensures that we deliver communications that inform better clinical decision making and achieve our commitment to change lives for the better.
K Health, in its AI-based telehealth app, is using AI and big data to help users access accurate information on their symptoms and connect with physicians; BioSymetrics is using AI and machine learning to provide a platform and models to help pharmaceuticalcompanies to identify targets for drug discovery; while Bayer's AI-enabled Calantic™ Digital (..)
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content